NEW YORK (GenomeWeb) – Danaher today released its earnings guidance for 2017, saying that it anticipates net earnings per share of $3.13 to $3.23.

On an adjusted basis, the company expects earnings of $3.85 to $3.95 per share, which assumes core revenue growth of 3 percent to 4 percent over 2016. The current average analyst estimate for earnings per share in 2017 is $3.95.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.